Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...

Eli LillyDemand for weight-loss drugs in India has shot up.And rivals Novo Nordisk and Eli Lilly are battling for market ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Health news highlights the booming demand for obesity drugs in India with companies like Eli Lilly and Novo Nordisk vying for ...

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

The demand for weight-loss medications is rapidly increasing in India, with competitors Eli Lilly and Novo Nordisk vying for ...

Pharmarack Technologies a market leader in pharmaceutical digital supply chain and Indian pharmaceutical market intelligence, in collaboration with the Indian Pharmaceutical Alliance (IP Alliance), ...

Citing data from India-based market analysis firm Pharmarack Technologies, the publication said Lilly (NYSE:LLY) recorded ₹126M ($1.5M) worth of Mounjaro sales last month.

Citing data from India-based market analysis firm Pharmarack Technologies, the publication said Lilly (NYSE:LLY) recorded ₹126M ($1.5M) worth of Mounjaro sales last month.

Mumbai: Pharmarack Technologies Pvt. Ltd., in collaboration with the Indian Pharmaceutical Alliance (IPA), has released a report titled "Changing Dynamics of Indian Pharma Supply Chain," offering ...

The healthcare infrastructure in India has grown tremendously after the pandemic, as per a report by Pharmarack. While the number of hospitals has jumped from 43,500 in 2019 to 54,000 in 2024, the ...

They saw a double-digit growth compared with two years ago, at 17.2%, 10.7% and 19.2%, according to the Indian Pharma Industry Performance report published by Pharmarack, a market research firm.